Risk-Adapted Preemptive Therapy for Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

  • MORI Takehiko
    Division of Hematology, Department of Medicine, Keio University School of Medicine
  • AISA Yoshinobu
    Division of Hematology, Department of Medicine, Keio University School of Medicine
  • NAKAZATO Tomonori
    Division of Hematology, Department of Medicine, Keio University School of Medicine
  • IKEDA Yasuo
    Division of Hematology, Department of Medicine, Keio University School of Medicine
  • OKAMOTO Shinichiro
    Division of Hematology, Department of Medicine, Keio University School of Medicine

Search this article

Journal

Citations (2)*help

See more

References(5)*help

See more

Details 詳細情報について

Report a problem

Back to top